Evoke Pharma (EVOK) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts EVOK Hot Sheet
Join SI Premium – FREE
Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.37), $0.08 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Bernstein SocGen Group Upgrades AENA SME SA (AENA:SM) (ANNSF) to Outperform
- Barclays Upgrades CubeSmart (CUBE) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
